132 related articles for article (PubMed ID: 17216011)
1. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
[TBL] [Abstract][Full Text] [Related]
2. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
[TBL] [Abstract][Full Text] [Related]
3. [Report on the first year of the activity of the National Oncological RD Consortium].
Tímár J
Magy Onkol; 2002; 46(4):297-300. PubMed ID: 12563351
[TBL] [Abstract][Full Text] [Related]
4. [Activity of the National Oncology R&D Consortium in 2004].
Tímár J;
Magy Onkol; 2005; 49(1):3-7. PubMed ID: 15902326
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic applications of epigenetics.
Miyamoto K; Ushijima T
Jpn J Clin Oncol; 2005 Jun; 35(6):293-301. PubMed ID: 15930038
[TBL] [Abstract][Full Text] [Related]
6. Hereditary cancer in adults.
Lynch HT; Fusaro RM; Lynch J
Cancer Detect Prev; 1995; 19(3):219-33. PubMed ID: 7750110
[TBL] [Abstract][Full Text] [Related]
7. Genetics of colorectal and breast cancer.
Garrett CT; Liscia DS; Nasim S; Ferreira-Gonzalez A
Clin Lab Med; 1995 Dec; 15(4):957-71. PubMed ID: 8838233
[TBL] [Abstract][Full Text] [Related]
8. [Report of the National Oncology Research and Developement Consortium, 2003].
Tímár J
Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
10. [Gene expression profiles in the diagnosis and prognosis of cancer].
Kopper L; Tímár J
Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
Minamoto T; Mai M; Ronai Z
Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer in an MSH2 gene mutation carrier.
Westenend PJ; Schütte R; Hoogmans MM; Wagner A; Dinjens WN
Hum Pathol; 2005 Dec; 36(12):1322-6. PubMed ID: 16311127
[TBL] [Abstract][Full Text] [Related]
13. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
Froggatt NJ; Green J; Brassett C; Evans DG; Bishop DT; Kolodner R; Maher ER
J Med Genet; 1999 Feb; 36(2):97-102. PubMed ID: 10051005
[TBL] [Abstract][Full Text] [Related]
14. Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome.
Jarrar AM; Church JM; Fay S; Kalady MF
Dis Colon Rectum; 2009 Dec; 52(12):1949-55. PubMed ID: 19934914
[TBL] [Abstract][Full Text] [Related]
15. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
[TBL] [Abstract][Full Text] [Related]
16. Multistep carcinogenesis in colorectal cancers.
Takami K; Yana I; Kurahashi H; Nishisho I
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():190-6. PubMed ID: 8629105
[TBL] [Abstract][Full Text] [Related]
17. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].
Lakatos PL; Lakatos L
Orv Hetil; 2006 Mar; 147(10):449-55. PubMed ID: 16573174
[TBL] [Abstract][Full Text] [Related]
18. [Sporadic and hereditary colorectal cancer. Pathogenetically different with different therapeutic indications].
Weitz J; Knaebel HP; Büchler MW
Chirurg; 2003 Aug; 74(8):717-25. PubMed ID: 12928792
[TBL] [Abstract][Full Text] [Related]
19. [The molecular diagnosis of cancer].
Barrera Saldaña H; Martínez Garza S; Ortiz López R
Rev Invest Clin; 2003; 55(2):128-37. PubMed ID: 12827915
[TBL] [Abstract][Full Text] [Related]
20. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
Couturier D
Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
